114 related articles for article (PubMed ID: 34592610)
1. Elevated CA125 is Related to Stroke Due to Cancer- Associated Hypercoagulation.
Maezono-Kandori K; Ohara T; Fujinami J; Makita N; Tanaka E; Mizuno T
J Stroke Cerebrovasc Dis; 2021 Dec; 30(12):106126. PubMed ID: 34592610
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and tumor markers in ischemic stroke patients with active cancer.
Nezu T; Hosomi N; Naito H; Aoki S; Torii T; Kurashige T; Sugiura T; Kuzume D; Morimoto Y; Yoshida T; Yagita Y; Oyama N; Shiga Y; Kinoshita N; Kamimura T; Ueno H; Ohshita T; Maruyama H
Intern Emerg Med; 2022 Apr; 17(3):735-741. PubMed ID: 34596824
[TBL] [Abstract][Full Text] [Related]
4. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology.
Schwarzbach CJ; Schaefer A; Ebert A; Held V; Bolognese M; Kablau M; Hennerici MG; Fatar M
Stroke; 2012 Nov; 43(11):3029-34. PubMed ID: 22996958
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Associated Hypercoagulation Increases the Risk of Early Recurrent Stroke in Patients with Active Cancer.
Fujinami J; Ohara T; Kitani-Morii F; Tomii Y; Makita N; Yamada T; Kasai T; Nagakane Y; Nakagawa M; Mizuno T
Cerebrovasc Dis; 2018; 46(1-2):46-51. PubMed ID: 30064137
[TBL] [Abstract][Full Text] [Related]
6. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
[TBL] [Abstract][Full Text] [Related]
7. [A clinical study on the pathogenesis of lung cancer-related cerebral infarction].
Xie XR; Qin C; Chen L; Cheng DB; Huang JY; Wei XX; Yu LX; Liang ZJ
Zhonghua Nei Ke Za Zhi; 2017 Feb; 56(2):99-103. PubMed ID: 28162178
[No Abstract] [Full Text] [Related]
8. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
9. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
10. Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.
Luo G; Liu C; Guo M; Cheng H; Lu Y; Jin K; Liu L; Long J; Xu J; Lu R; Ni Q; Yu X
Ann Surg; 2017 Apr; 265(4):800-805. PubMed ID: 28267695
[TBL] [Abstract][Full Text] [Related]
11. Potential Pathogenesis and Biomarkers of Kidney Cancer-Related Stroke.
Jiang H; Qin C; Cheng D; Lu Q; Huang G; Wang D; Yang H; Liang Z
Med Sci Monit; 2017 May; 23():2292-2298. PubMed ID: 28505148
[TBL] [Abstract][Full Text] [Related]
12. Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer.
Namikawa T; Kawanishi Y; Fujisawa K; Munekage E; Iwabu J; Munekage M; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Surg Today; 2018 Apr; 48(4):388-394. PubMed ID: 29043453
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X
Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902
[TBL] [Abstract][Full Text] [Related]
14. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination.
Emoto S; Ishigami H; Yamashita H; Yamaguchi H; Kaisaki S; Kitayama J
Gastric Cancer; 2012 Apr; 15(2):154-61. PubMed ID: 21892754
[TBL] [Abstract][Full Text] [Related]
16. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
[TBL] [Abstract][Full Text] [Related]
18. Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden.
Liu L; Xu HX; Wang WQ; Wu CT; Xiang JF; Liu C; Long J; Xu J; Fu de L; Ni QX; Houchen CW; Postier RG; Li M; Yu XJ
Oncotarget; 2016 Feb; 7(5):5943-56. PubMed ID: 26745601
[TBL] [Abstract][Full Text] [Related]
19. Better Predictive Value of Cancer Antigen125 (CA125) as Biomarker in Ovary and Breast Tumors and its Correlation with the Histopathological Type/Grade of the Disease.
Nazmeen A; Maiti S; Mandal K; Roy SK; Ghosh TK; Sinha NK; Mandal K
Med Chem; 2017; 13(8):796-804. PubMed ID: 28440189
[TBL] [Abstract][Full Text] [Related]
20. Elevated Serum Level of CA125 Is a Biomarker That Can Be Used to Alter Prognosis Determined by BRCA Mutation and Family History in Ovarian Cancer.
Liu W; Wang Z; Ma J; Hou Y; Zhao J; Dong B; Tu S; Wang L; Guo Y
Genet Test Mol Biomarkers; 2017 Sep; 21(9):547-554. PubMed ID: 28799806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
